COVID-19, caused by the SARS-CoV-2 virus, has profoundly reshaped global healthcare since its emergence in December 2019. By 2024, the pandemic has resulted in approximately
Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of Longidaza (3000 U) for treating
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the delivery of preventative care interventions
ACG aims to cut packaging and manufacturing emissions by 5.2% year-on-year in line with its SBTi goals Sustainability in the 21st century is an essential
The pharmaceutical industry is undergoing a major transformation, as clinical trials become increasingly data heavy and digital-based. Traditional methods of data collection are gradually being
Despite the best efforts of pharmaceutical manufacturers and regulators to improve the security and traceability of drug products, counterfeits continue to proliferate and cause considerable
The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption of technology through decentralized clinical
Q14 is a new guideline detailing the elements of minimal and enhanced approaches for analytical procedure development. While the traditional minimal development approach remains valid,
Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However, they serve distinct purposes and
Share this article According to a recent poll of Pharmaceutical Technology readers (conducted by GlobalData)[i] 43% of respondents said that environmental issues were the most